Loading clinical trials...
Loading clinical trials...
The effect of botulinum neurotoxin type A intradermal injection in will be evaluated in 4 patients with clinical diagnosis of burning mouth syndrome involving the anterior two-thirds of the tongue and...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Presidio Ospedaliero Garibaldi-Centro
Collaborators
NCT05819697 · Burning Mouth Syndrome
NCT07381361 · Burning Mouth Syndrome, Low Level Laser Therapy
NCT07344909 · Burning Mouth Syndrome, Orofacial Pain, and more
NCT05309070 · Burning Mouth Syndrome
NCT05871580 · Burning Mouth Syndrome, Quality of Life, and more
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions